Investor Relations

Press Releases

 
Press Releases
  Date Title View
Apr 19, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 19, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its first quarter 2017 financial results before the market opens on Wednesday, April 26, 2017. United Therapeutics will host a teleconference on Wednesday, April 26, 2017, at 9...
Apr 3, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 3, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that regulatory delays will result in postponement of the planned U.S. launch of the RemoSynch™ Implantable System for Remodulin® until 2018. "United Therapeutics' commitment to bringing...
Mar 31, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 31, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that the U.S. Patent and Trademark's Office (USPTO) Patent Trial and Appeal Board (PTAB) issued a Final Written Decision in connection with the inter partes review (IPR) of United Therapeutics' U.S. Pate...
Mar 9, 2017
MANHASSET, N.Y. and SILVER SPRING, Md., March 9, 2017 /PRNewswire/ -- Northwell Health's Feinstein Institute for Medical Research and United Therapeutics Corporation (NASDAQ: UTHR) announced today a strategic partnership focused on the application of bioelectronic medicine and cell therapy to cardiology, hypertension and post-transplant tolerance i...
Mar 7, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Barclays Global Healthcare Conference in Mi...
Feb 28, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Cowen and Company 37th Annual Health Care C...
Feb 22, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2016. "Our annual 2016 financial results reflect continued growth as net revenues reached $1.6 billion and earnings exceeded...
Feb 15, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its fourth quarter and annual 2016 financial results before the market opens on Wednesday, February 22, 2017. United Therapeutics will host a teleconference on Wednesday, Februa...
Jan 5, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Jan. 5, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 35th Annual J.P. Morgan Healthcare Conferenc...
Oct 27, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 27, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2016. "Our financial performance continues its strength this quarter," said Martine Rothblatt, Ph.D., United Therapeutics' Chairman a...
1
... NextLast
= add release to Briefcase